This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Balance Training in Patients With Chronic Obstructive Pulmonary Disease (COPD)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2011 by Roger Goldstein, West Park Healthcare Centre.
Recruitment status was:  Recruiting
Ontario Lung Association
Information provided by (Responsible Party):
Roger Goldstein, West Park Healthcare Centre Identifier:
First received: August 22, 2011
Last updated: August 24, 2011
Last verified: August 2011
A growing body of evidence suggests that individuals with chronic lung disease have important deficits in balance control that may be associated with an increased risk of falls. The main purpose of this study is to examine the effects of a balance training program on measures of balance and fall risk in people with chronic lung disease.

Condition Intervention
Chronic Obstructive Pulmonary Disease Behavioral: Balance training program

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Randomized Controlled Trial of Balance Training in Patients With Chronic Obstructive Pulmonary Disease

Resource links provided by NLM:

Further study details as provided by Roger Goldstein, West Park Healthcare Centre:

Primary Outcome Measures:
  • Berg Balance Scale [ Time Frame: All outcomes will be assessed upon admission to pulmonary rehabilitation (baseline) and again upon completion of the program, an expected average of 6 weeks from baseline. ]
  • Balance Evaluation Systems Test [ Time Frame: At baseline and 6 weeks. ]

Secondary Outcome Measures:
  • Balance confidence/falls self-efficacy [ Time Frame: At baseline and 6 weeks. ]
  • Functional strength [ Time Frame: At baseline and 6 weeks. ]
  • Self-reported physical function [ Time Frame: At baseline and 6 weeks. ]

Estimated Enrollment: 46
Study Start Date: August 2011
Estimated Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Balance Training
The treatment group will complete a specific balance training program in addition to conventional pulmonary rehabilitation.
Behavioral: Balance training program
Training will consist of 30 minute sessions 3 times/week for 6 weeks in keeping with best practice guidelines for older adults. Sessions will be supervised by physical therapists, using a circuit training approach with different stations designed to target specific areas of impairment. Participants will work through stations in a group setting; however, will receive individualized exercise prescription regarding level of difficulty and exercise progression.
No Intervention: Usual care
The control group will undergo the usual pulmonary rehabilitation program offered at our centre with no additional balance training classes.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Diagnosis of COPD; a self-report of decline in balance or fall in the last 5 years or a recent near fall; smoking history greater than 10 pack years; and are able to provide written informed consent.

Exclusion Criteria:

  • Inability to communicate because of language skills, hearing or cognitive impairment; and evidence of a neurological or musculoskeletal condition that severely limits mobility and postural control (e.g., cerebrovascular accident, advanced Parkinson's disease, amputation).
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01424098

Contact: Marla K Beauchamp, MSc.PT 416-243-3600 ext 3665

Canada, Ontario
West Park Healthcare Centre Recruiting
Toronto, Ontario, Canada, M6M2J5
Contact: Marla K Beauchamp, MSc.PT    416-243-3600 ext 3665   
Sponsors and Collaborators
Roger Goldstein
Ontario Lung Association
Principal Investigator: Dina Brooks, PhD University of Toronto
Principal Investigator: Roger S Goldstein, MD West Park Healthcare Centre
Study Chair: Marla K Beauchamp, MSc.PT University of Toronto
Study Chair: Tania Janaudis-Ferreira, PhD West Park Healthcare Centre
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Roger Goldstein, Director, Respiratory Medicine, West Park Healthcare Centre Identifier: NCT01424098     History of Changes
Other Study ID Numbers: Goldstein_OTSBalanceRCT_2012
Study First Received: August 22, 2011
Last Updated: August 24, 2011

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases processed this record on September 21, 2017